Videos de Experimentos Relacionados
¿Qué es la "hipertensión"?
1Blood Pressure Unit, Beaumont Hospital, Dublin, Ireland.
Lancet (London, England)
|May 20, 1999
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Erratum: Centrality-Dependent Modification of Jet-Production Rates in Deuteron-Gold Collisions at sqrt[s_{NN}]=200 GeV [Phys. Rev. Lett. 116, 122301 (2016)].
Physical review letters·2025
Same author
Quantifying the influence of climate change on pesticide risks in drinking water.
The Science of the total environment·2025
Same author
International consensus statement on the use of ultrasound in hidradenitis suppurativa.
Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author
Disentangling Centrality Bias and Final-State Effects in the Production of High-p_{T} Neutral Pions Using Direct Photon in d+Au Collisions at sqrt[s_{NN}]=200 GeV.
Physical review letters·2025
Same author
Review: Sperm cryopreservation in wild small ruminants: morphometric, endocrine and molecular basis of cryoresistance.
Animal : an international journal of animal bioscience·2023
Same author
Measurement of Direct-Photon Cross Section and Double-Helicity Asymmetry at sqrt[s]=510 GeV in p[over →]+p[over →] Collisions.
Physical review letters·2023
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026